NDC 0378-1940

Lenalidomide

Lenalidomide

Lenalidomide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Lenalidomide.

Product ID0378-1940_76f6c1e7-985b-43d9-892c-849df50ae80e
NDC0378-1940
Product TypeHuman Prescription Drug
Proprietary NameLenalidomide
Generic NameLenalidomide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-09-03
Marketing CategoryANDA /
Application NumberANDA213912
Labeler NameMylan Pharmaceuticals Inc.
Substance NameLENALIDOMIDE
Active Ingredient Strength25 mg/1
Pharm ClassesThalidomide Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0378-1940-01

100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01)
Marketing Start Date2022-09-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lenalidomide" or generic name "Lenalidomide"

NDCBrand NameGeneric Name
0378-1936LenalidomideLenalidomide
0378-1937LenalidomideLenalidomide
0378-1940LenalidomideLenalidomide
0378-1941LenalidomideLenalidomide
0480-1242LenalidomideLenalidomide
0480-1243LenalidomideLenalidomide
0480-1244LenalidomideLenalidomide
0480-1246LenalidomideLenalidomide
43598-511LenalidomideLenalidomide
43598-512LenalidomideLenalidomide
43598-513LenalidomideLenalidomide
43598-514LenalidomideLenalidomide
43598-515LenalidomideLenalidomide
43598-516LenalidomideLenalidomide
47781-484LENALIDOMIDELenalidomide
47781-485LENALIDOMIDELenalidomide
47781-486LENALIDOMIDELenalidomide
47781-488LENALIDOMIDELenalidomide
59572-402RevlimidLenalidomide
59572-405RevlimidLenalidomide

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.